ஸெநெக இந்தியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ஸெநெக இந்தியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ஸெநெக இந்தியா Today - Breaking & Trending Today
Stocks to Watch: UCO Bank, Max Healthcare, Gulf Oil, Sun Pharma, AstraZeneca Pharma among others freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
AstraZeneca Pharma India Limited and Sun Pharma enter into transition supply agreement equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca Pharma India announced that the company and Abbott Healthcare have on 27 May 2021 mutually terminated the Distribution Agreement for distribution of Dapagliflozin, an innovative Type 2 diabetes medicine in India under brand name Gledepa and the combination of Dapagliflozin with Metformin under the brand name Gledepa Met. AstraZeneca India will continue to independently market Dapagliflozin, the combinations of Dapagliflozin and Metformin as well as Dapagliflozin and Saxagliptin in India under the brand names Forxiga Xigduo and Qtern respectively. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) ....
AstraZeneca Pharma India announced that in 2016 the company had entered into a distribution services agreement with Sun Pharma Laboratories (Sun Pharma) for the distribution of Dapagliflozin, an innovative Type 2 diabetes medicine, in India. Under the said Agreement, Sun Pharma promoted and distributed Dapagliflozin under the brand name Oxra. Sun Pharma also gained the rights to promote and distribute the combination of Dapagliflozin with Metformin under the brand name Oxramet and the combination of Dapagliflozin and Saxagliptin under the brand name Oxraduo. Now, AstraZeneca India and Sun Pharma have discontinued its existing Distribution Services Agreement signed in 2016 by entering into a Transition Supply Agreement with effect from 28 May 2021. Under the Transition Supply Agreement, Sun Pharma will continue to promote and distribute Dapagliflozin and the combinations of Dapagliflozin with Metformin under the brand Oxra and Oxramet until such period of time as mutually ....
Here are the top stocks to track in today s session: Bajaj Auto:Bajaj Auto has entered into an initial pact with the Maharashtra government for setting up a production plant at Chakan at an estimated investment of Rs 650 crore. Wipro: Wipro on Tuesday said its up to Rs 9,500-crore share buyback programme will commence on December 29 and close on January 11, 2021. In another update, the company has inked $700 million takeover deal with Metro AG and over 1,300 staff from German company would move to the Indian firm. Punjab & Sind Bank: The Centre, in a first move of its kind, has issued Rs 5,500 crore in zero-coupon bonds for recapitalising Punjab and Sind Bank and allowed it to park the paper in its held-to-maturity category at face value rather than the discounted market rate. ....